ACAONE 100MG CAP

Acaone 100mg contains acalabrutinib, a targeted cancer medicine belonging to the BTK inhibitor class. BTK is involved in B-cell receptor signaling, which can contribute to the growth and survival of abnormal B cells.

By inhibiting BTK signaling, acalabrutinib can help reduce the proliferation and survival of malignant B cells. It is used for specific hematological malignancies and should be prescribed based on the patient’s diagnosis and treatment history.

Because acalabrutinib can cause clinically important adverse effects and drug interactions, treatment requires specialist supervision and appropriate monitoring.